Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Those compounds primarily target GLP-1 receptors
In RSL3-induced glioblastoma cell models, excessive activation of NF-KB represses ATF4 and SLC7A11, causing overproduction of lipid peroxidation byproducts and exacerbating ferroptosis (126)
Fatigue: Some participants reported fatigue or tiredness during treatment periods
Doses Per Vial Vial duration varies by dose escalation phase: 3mg vial: At 0.25mg/week = 12 weeks At 0.5mg/week = 6 weeks At 1mg/week = 3 weeks At 2.4mg/week = 1.25 weeks 5mg vial: At 0.25mg/week = 20 weeks At 0.5mg/week = 10 weeks At 1mg/week = 5 weeks At 1.7mg/week = ~3 weeks At 2.4mg/week = ~2 weeks A 5mg vial can cover the entire first 4 months of a slow escalation protocol starting at 0.25mg
161 , S85S95 (2009)
TAM-tastic: from resistance to resilience in cancer
